Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm from 14 Sep 650x100px
Document › Details

Bioké (Cell Signaling Technology Europe B.V.). (9/16/24). "Press Release: Bioké and e-Blot Announce a Distribution Agreement in the European Region". Leiden.

Region Region Europe
Organisations Organisation Cell Signaling Technology Europe B.V. (Bioké)
  Group Cell Signaling Technology (CST) (Group)
  Organisation 2 e-Blot Life Science (Shanghai) Co., Ltd.
Products Product Touch Imager electronic blot imaging system
  Product 2 immunoblot
Index term Index term Cell Signaling Technology–e-Blot Life Science: imaging system, 202409– distribution of Touch Imager system by Bioké in 12 European countries
Person Person Kranenborg, Koos (Cell Signaling Technology 201306 Director Sales + Operations at BIOKÉ)
     


BIOKÉ, a leading distributor of life science technologies throughout Europe for more than 20 years and a business unit of Cell Signaling Technology (CST) Europe, has partnered with e-BLOT, a leading supplier of biomedical innovation tools and solutions, to distribute their Western Blot devices across Netherlands, Belgium, Luxembourg, United Kingdom of Great Brittain and Northern Ireland, Ireland, Germany, Austria, Denmark, Norway, Finland and Iceland.

e-BLOT, has earned widespread recognition in the industry for its cutting-edge technology and excellent product quality since its inception. Imaging technology plays a crucial role in the life and health sector, with approximately 30% of experiments or diagnostics relying on imaging technology for accurate judgments or conclusions.

The Touch Imager electronic blot imaging system provided by e-BLOT revolutionizes traditional lens imaging technology by pioneering the application of contact imaging technology to the imaging field, ushering in a new era of chemiluminescence imaging. This technology significantly improves imaging quality and efficiency with sensitivity and quantitative dynamic range two orders of magnitude higher than traditional cold CCD technology. After the introduction of the Touch Imager in 2021, the Touch Imager is already the choice of 600 academic and biotech customers worldwide.

By combining BIOKÉ's extensive European distribution network with e-BLOTs cutting-edge technology, this agreement, which is effective immediately, will provide researchers in these European countries with access to this revolutionary chemiluminescence imaging device.
Mr. Zhang, the founder of e-BLOT, is full of expectations for this collaboration. He stated, "We are very pleased with the opportunity to cooperate with BIOKÉ / CST and hope to promote this collaboration by leveraging our mutual strengths”. Koos Kranenborg, General Manager Europe BIOKÉ, is excited about the collaboration. He expressed, "We are eager to provide our customers with the e-BLOTs Touch Imager. This cutting-edge instrument offers exceptional data quality and enhanced throughput, ensuring our customers receive top-notch results”.


About e-BLOT

e-BLOT Life Science (Shanghai) Co., Ltd. is a cutting-edge biotechnology company based in Shanghai, China, founded in 2017 by a group of PhDs from diverse scientific backgrounds. The company has pioneered innovative imaging technology, leading to the launch of the world’s first lens-free Western Blot chemiluminescence imaging system, the Touch Imager, in November 2021. The Touch Imager sets new standards in the field with its superior sensitivity, dynamic range, and unmatched imaging speed. Its excellence has been recognized globally, earning prestigious awards such as the German Red Dot Design Award and the Shanghai Magnolia Best Technical Innovation Award. Since its launch, the Touch Imager has been installed in over 600 labs worldwide, contributing to more than 300 published scientific papers.


About BIOKÉ

Founded in 2004, BIOKÉ is an experienced and knowledgeable company that provides innovative products with the highest quality in the life science industry throughout Europe. BIOKÉ delivers unique and best-in-class reagents, consumables and instruments for: Next-Generation Sequencing (NGS), Cloning and Functional Analysis, Single Cell research, Sample Preparation & Analysis, and RNA Technologies. In 2009 BIOKÉ was acquired by Cell Signaling Technology (CST). CST is the market leader in the development of high-quality antibody products and technologies. BIOKÉ operates now as a business unit within the CST organization. BIOKÉ holds offices in Leiden, the Netherlands. For additional information please visit the website at bioke.com.

   
Record changed: 2024-09-26

Advertisement

Picture Berlin Partner Top News CareSyntax Raises $61m for Bio Cheese 650x200px

More documents for Cell Signaling Technology (CST) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants 650x300px




» top